DAB2IP and breast cancer: We determined the effect of NF-κB activation in DAB2IP-low Luminal A breast cancer by profiling RELA, RELB, and NFKB2 genomic binding and gene expression using ChIP-Seq in stable DAB2IP knockdown and control T47D cells.